IDYA (IDEAYA Biosciences) יחס שווי שוק לשווי בספרים

IDEAYA Biosciences (IDYA) is implementing AI platforms for the rapid discovery of genetic targets, replacing routine laboratory work with digital modeling. The business relies on strategic alliances with major pharmaceutical companies to develop combination therapies. This price chart, confirming the market valuation, records the indicator at 2.64. Growth prospects depend on the protection of intellectual property and successful regulatory approval.

This ratio compares the market value of the business to its net assets, measuring the premium investors are willing to pay for future growth beyond the book value. For IDEAYA Biosciences (IDYA), the dynamics of the market value to book value ratio reflect market confidence in management's scientific expertise and the potential of the oncology pipeline, transforming tangible resources into strategic capital.